Riskpilot← Back to searchSign inGet full accessSuper Synbiotics AB
ABActiveOrg 5590051313Malmskillnadsgatan 44 ARetail sale of other food · NACE 4727Est. 20151-4 employees
Revenue 2024
SEK 13,2M
-5% vs 2023
EBITDA margin
-2.5%
-3410% vs 2023
Equity ratio
48.5%
Financial strength
Net profit 2024
SEK -325K
-1003% vs 2023
| Revenue | SEK 13,2M | -5% |
| EBITDA | SEK -331K | -3410% |
| Net profit | SEK -325K | -1003% |
| Total assets | SEK 8,2M | +25% |
| Equity | SEK 4M | -8% |
| Employees | — | — |
Legal name
Super Synbiotics AB
Org number
5590051313
Legal form
Aktiebolag
NACE code
4727 · Retail sale of other food
Founded
25 februari 2015
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas av Nählstedt, Bengt Peter i förening med Bengmark, David Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Import, förpackning, hantering, lagerhållning och distribution i parti och minut av kosttillskott, samt därmed förenlig verksamhet.
Address
Malmskillnadsgatan 44 A
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 13 887 | 15 457 | 17 951 | 16 590 | 14 486 | 13 978 | 13 240 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −114 | 2 540 | 6 731 | 6 290 | 5 292 | 2 790 | 1 788 | −1 178 | 10 | −331 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −114 | 2 540 | 6 731 | 6 290 | 5 292 | 2 790 | 1 788 | −1 178 | 10 | −331 |
| Net financials | — | — | — | −2 | 18 | 4 | — | — | 26 | 6 |
| Profit before tax | −114 | 2 540 | 6 731 | 6 288 | 5 310 | 2 794 | 1 788 | −1 179 | 36 | −325 |
| Tax | −0 | −534 | −1 482 | −1 387 | −1 142 | −599 | −375 | −0 | −0 | −0 |
| Net profit | −114 | 2 006 | 5 249 | 4 901 | 4 168 | 2 195 | 1 413 | −1 179 | 36 | −325 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 243 | 4 624 | 8 965 | 13 755 | 11 032 | 10 707 | 9 868 | 6 448 | 6 582 | 8 243 |
| Equity | 221 | 2 228 | 6 191 | 10 692 | 8 859 | 7 554 | 7 467 | 4 289 | 4 325 | 4 000 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 22 | 2 396 | 2 774 | 3 063 | 2 173 | 3 154 | 2 401 | 2 159 | 2 257 | 4 243 |
| Total debt | 22 | 2 396 | 2 774 | 3 063 | 2 173 | 3 154 | 2 401 | 2 159 | 2 257 | 4 243 |
EBITDA margin
-2.5%
This company
15.8%
Market median
-116% vs market
20152024
Equity ratio
48.5%
This company
38.2%
Market median
+27% vs market
20152024
Return on equity
-8.1%
This company
18.4%
Market median
-144% vs market
20152024
Net profit margin
-2.5%
This company
8.1%
Market median
-131% vs market
20152024
Asset turnover
1.61×
This company
1.12×
Market median
+44% vs market
20152024
Debt / equity
1.06×
This company
0.62×
Market median
-71% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-02-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
GH Chief Auditor | Chief Auditor | 2021 | — | — |
KV Chief Auditor | Chief Auditor | 2026 | — | — |
TL Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Synbiotics AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Synbiotics AB
Super Synbiotics AB Board members of Super Synbiotics AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gabriel Hannes Sandén | Chief Auditor | 0 companies |
| Karl Vilhelm Andersson | Chief Auditor | 0 companies |
| Tom Ludvig Ekelund | Chief Executive Officer | 0 companies |
| Eva Kerstin Holmgren | Board of Directors | 0 companies |
| Dan Samuel Bengmark | Board of Directors | 0 companies |
| Carl Gösta Fredrik Henge | Board of Directors | 0 companies |
| Bengt Tore Herbert Mårtensson | Deputy Board Member | 0 companies |
| Francesca Jusanna Brandström | Board of Directors | 0 companies |
| David Bengmark | Deputy Board Member | 0 companies |
| Bengt Peter Nählstedt | Chairman | 0 companies |
| Per Lennart Krister Persson | Board of Directors | 0 companies |
| Irini Lazou Ahrén | Board of Directors | 0 companies |